Results 291 to 300 of about 157,526 (353)
Durvalumab-Based First-Line Chemoimmunotherapy in Advanced Biliary Tract Cancer: Real-World Outcomes and Prognostic Factors-A Turkish Oncology Group Study. [PDF]
Efil SC +33 more
europepmc +1 more source
Single-cell multi-omics in biliary tract cancers: decoding heterogeneity, microenvironment, and treatment strategies. [PDF]
Tang N, Li J, Gu A, Li M, Liu Y.
europepmc +1 more source
Therapeutic T cells with 3-in-1 strategy for the treatment of biliary tract cancer. [PDF]
Wan X +7 more
europepmc +1 more source
A cost-effectiveness analysis comparing pembrolizumab combined with chemotherapy versus chemotherapy alone for advanced biliary tract cancer: US and China perspectives. [PDF]
Zhang C +6 more
europepmc +1 more source
Immunotherapy change overcomes acquired resistance after chemo-immunotherapy in unresectable biliary tract cancer. [PDF]
Chen X +16 more
europepmc +1 more source

